维普中文期刊产品整合服务
605篇 您的检索式:作者名="Roger V"
    题名 作者 年代 出处 被引量
12018加拿大心境障碍与焦虑障碍治疗协作组/国际双相障碍学会指南:双相障碍的管理显示文摘加拿大心境障碍与焦虑障碍治疗协作组(Canadian Network for Mood and Anxiety Treatments,CANMAT)曾于2005年发布了第1版双相障碍管理指南,并分别于2007、2009和2013年对该指南进行了更新,其中最近的2次更新是与国际双相障碍学会(International Society for Bipolar Disorders,ISBD)合作完成。2018版CANMAT/ISBD双相障碍治疗指南(以下简称指南)反映了自2005年首版指南发表以来本领域取得的重大进展,包括疾病诊断与疾病管理的更新以及药物治疗与心理治疗的近期研究进展。这些前沿进展中综合考虑了循证证据的级别,并基于治疗疗效、临床实践经验、安全性、耐受性和药物导致的转相风险等,对一线、二线及三线治疗方案进行了简明而清晰的推荐。本指南中新增内容涵盖了双相Ⅰ型障碍(BD-Ⅰ)的躁狂发作急性期、抑郁发作急性期和双相障碍维持期的一线及二线治疗推荐等级划分。这种对治疗推荐等级的划分综合考虑了治疗方法对双相障碍不同时相的影响,将进一步帮助临床医生做出基于循证证据的治疗决策。锂盐、喹硫平、双丙戊酸盐、阿塞那平、阿立哌唑、帕利哌酮、利培酮和卡利拉嗪单药或联合使用被推荐为躁狂发作急性期的一线治疗选择。BD-Ⅰ抑郁期的一线治疗选择包括喹硫平、鲁拉西酮、锂盐、拉莫三嗪单药,鲁拉西酮联合锂盐或双丙戊酸盐或拉莫三嗪辅助治疗。尽管急性期治疗有效的药物通常应继续用于BD-Ⅰ的维持期治疗,但也存在一些特殊情况(例如抗抑郁药)。现有数据表明,锂盐、喹硫平、双丙戊酸盐、拉莫三嗪、阿塞那平和阿立哌唑单药或联合治疗应被视为维持治疗的初始或更换治疗方案时的一线选择。除了探讨BD-Ⅰ的相关问题外,本指南中还对双相Ⅱ型障碍(BD-Ⅱ)的临床管理进行了系统回顾并给予治疗推荐,同时针对特殊人群也有相关推荐,如处于各个生殖周期的女性、儿童、青少年和老年人。此外,本指南中还讨论了特定精神疾病及共病(如物质滥用、焦虑障碍和代谢性疾病)的影响。最后,本指南中概述了安全性和药物监测的相关问题。CANMAT/ISBD工作组希望本指南能够成为全球临床医生的实用工具。Lakshmi N Yatham Sidney H Kennedy Sagar V Parikh Ayal Sehaffer David J Bond Benicio N Frey Verinder Sharma Benjamin I Goldstein Soham Rej Serge Beaulieu Martin Alda Glenda MaeQueen Roumen V Milev Arun Ravindran Claire O'Donovan Diane Mclntosh Raymond W Lam Gustavo Vazquez Flavio Kapczinski Roger S Melntyre Jan Kozicky Shigenobu Kanba Beny Lafer Trisha Suppes Joseph R Calabrese Eduard Vieta Gin Malhi Robert M Post Michael Berk 胡晨(译) 王刚(译) 2019中华精神科杂志2019,52,1:25
2Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association显示文摘Alan S. Go Dariush Mozaffarian Véronique L. Roger Emelia J. Benjamin Jarett D. Berry William B. Borden Dawn M. Bravata Shifan Dai Earl S. Ford Caroline S. Fox Sheila Franco Heather J. Fullerton Cathleen Gillespie Susan M. Hailpern John A. Heit Virginia J. 2013Circulation2013,,1:5
3Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association显示文摘Véronique L. Roger Alan S. Go Donald M. Lloyd-Jones Robert J. Adams Jarett D. Berry Todd M. Brown Mercedes R. Carnethon Shifan Dai Giovanni de Simone Earl S. Ford Caroline S. Fox Heather J. Fullerton Cathleen Gillespie Kurt J. Greenlund Susan M. Hailpern 2011Circulation2011,,4:4
4Executive Summary: Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association显示文摘Alan S. Go Dariush Mozaffarian Véronique L. Roger Emelia J. Benjamin Jarett D. Berry William B. Borden Dawn M. Bravata Shifan Dai Earl S. Ford Caroline S. Fox Sheila Franco Heather J. Fullerton Cathleen Gillespie Susan M. Hailpern John A. Heit Virginia J. 2013Circulation2013,,1:4
5Mortality Associated With Atrial Fibrillation in Patients With Myocardial Infarction: A Systematic Review and Meta-Analysis显示文摘Patricia Jabre Véronique L. Roger Mohammad H. Murad Alanna M. Chamberlain Larry Prokop Frédéric Adnet Xavier Jouven 2011Circulation2011,,15:2
6Executive Summary: Heart Disease and Stroke Statistics—2012 Update: A Report From the American Heart Association显示文摘Véronique L. Roger Alan S. Go Donald M. Lloyd-Jones Emelia J. Benjamin Jarett D. Berry William B. Borden Dawn M. Bravata Shifan Dai Earl S. Ford Caroline S. Fox Heather J. Fullerton Cathleen Gillespie Susan M. Hailpern John A. Heit Virginia J. Howard Bret 2012Circulation2012,,1:2
7Wild-type and inter-leukin-10-deficient regulatory T cells reduce effector T-cell-mediated gastreduedenitis in rag2-/- mice, but only wild-type regulatory T cells suppress Helicobacter pylori gastritis 显示文摘LEE Chung-wei RAO V P ROGERS A B 2007Infect Immun2007,675,6:1
8Kinetic basis for the substrate specificity during hydrolysis of phospholipids by secreted phospholipase A2 显示文摘ROGERS J YU B Z SERVES S V 1996Biochemistry1996,35,29:1
9Trends in heart failure incidence and survival in a community-based population显示文摘ROGER V L WESTON S A REDFIELD M M 2004JAMA2004,292,3:1
10In vitro replication of mouse hepatitis virus strain A59显示文摘Compton J R Rogers D B Holmes K V 1987J Virol1987,61,:1
11Deciphering the biology of My cobacterium tuberculosis from the complete genome sequence 显示文摘Cole S T Brosch R Parkhill J Gamier T Churcher C Harris D Gordon S V Eiglmeier K Gas S Barry C E Tekaia F Badcock K Basham D Brown D Chillingworth T Cormor R Davies R Devlin K FeltweU T Gentles S Hamlin N Holroyd S Hornsby T Jagels K Kroghs A McLean J Moule S Murphy L Oliver K Osborne J Quail M A Rafandream M A Rogers J Rutter S Seeger K Skelton J Squaraes R Squares S Sulston J E Taylo K Whitehead S Barrell B G 1998Nature1998,393,:1
12New concepts in the pathohiology of chronic obstructive pulmonary disease显示文摘Kim V Rogers TJ Criner GJ 2008Proc Am Thorac Soc2008,5,47:1
13New concepts in the patho- biology of chronic obstructive pulmonary disease 显示文摘KIM V ROGERS TJ CRINER GJ 2008Pree Am Thorae See2008,5,4:1
14Plant responses to atmospheric CO2 enrichment with emphasis on roots and the rhizosphere显示文摘ROGERS H H RUNION G B KRUPA S V 1994Environmental Pollution1994,83,:1
15Angiography,CT,sonography,and scitigraphy显示文摘ROGERS J V 1980AJR1980,134,:1
16Molecular and pharmacological characterization of dominant black coat color in sheep显示文摘Dag Inge V?ge Helge Klungland Dongsi Lu Roger D. Cone 1999Mammalian Genome1999,,1:1
17Multiphase ra- don generation and transport in porous materials 显示文摘ROGERS V C NIELSON K K 1991Health Physics1991,60,6:1
18The aRb rela- tion in the calculation of rain attenuation显示文摘OLSEN R ROGERS D V HODGE D 1978IEEE Transactions on Antennas and Propagation1978,26,2:1
19Heart disease and stroke statistics-2013 update: a report from the American Heart Association 显示文摘GO A S MOZAFFARIAN D ROGER V L 2013Circulation2013,127,1:1
20Heart disease and stroke statistics---2013 update:a report from the American Heart Association显示文摘Go A S Mozaffarian D Roger V L 0,,01:1
返回顶部 每页显示:
共31页 首页 上一页 第1页 下一页 末页 /31 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费